To determine the immune value of SERPINA1 in the tumor microenvironment (TME), we explored the connections between SERPINA1 expression and TMB and MSI, which have been confirmed to influence immunotherapy efficacy significantly [11,12]. The gene discussed is SERPINA1; the disease is neoplasm.